» Articles » PMID: 37276403

Heterogeneous Expression of Alternatively Spliced LncRNA Mediates Vascular Smooth Cell Plasticity

Overview
Specialty Science
Date 2023 Jun 5
PMID 37276403
Authors
Affiliations
Soon will be listed here.
Abstract

9p21.3 locus polymorphisms have the strongest correlation with coronary artery disease, but as a noncoding locus, disease connection is enigmatic. The lncRNA found in 9p21.3 may regulate vascular smooth muscle cell (VSMC) phenotype to contribute to disease risk. We observed significant heterogeneity in induced pluripotent stem cell-derived VSMCs from patients homozygous for risk versus isogenic knockout or nonrisk haplotypes. Subpopulations of risk haplotype cells exhibited variable morphology, proliferation, contraction, and adhesion. When sorted by adhesion, risk VSMCs parsed into synthetic and contractile subpopulations, i.e., weakly adherent and strongly adherent, respectively. Of note, >90% of differentially expressed genes coregulated by haplotype and adhesion and were associated with Rho GTPases, i.e., contractility. Weakly adherent subpopulations expressed more short isoforms of , and when overexpressed in knockout cells, suppressed adhesion, contractility, and αSMA expression. These data suggest that variable lncRNA penetrance may drive mixed functional outcomes that confound pathology.

Citing Articles

Conductive Microfibers Improve Stem Cell-Derived Cardiac Spheroid Maturation.

Gonzalez G, Molley T, LaMontagne E, Balayan A, Holman A, Engler A J Biomed Mater Res A. 2024; 113(1):e37856.

PMID: 39719888 PMC: 11703634. DOI: 10.1002/jbm.a.37856.


Development and disease-specific regulation of RNA splicing in cardiovascular system.

Jiang J, Wu H, Ji Y, Han K, Tang J, Hu S Front Cell Dev Biol. 2024; 12:1423553.

PMID: 39045460 PMC: 11263117. DOI: 10.3389/fcell.2024.1423553.


The 9p21.3 coronary artery disease risk locus drives vascular smooth muscle cells to an osteochondrogenic state.

Salido E, de Medeiros Vieira C, Mosquera J, Zade R, Parikh P, Suryavanshi S bioRxiv. 2024; .

PMID: 38853913 PMC: 11160673. DOI: 10.1101/2024.05.25.595888.


Understanding genomic medicine for thoracic aortic disease through the lens of induced pluripotent stem cells.

Singh A, Shetty D, Jacob A, Bayraktar S, Sinha S Front Cardiovasc Med. 2024; 11:1349548.

PMID: 38440211 PMC: 10910110. DOI: 10.3389/fcvm.2024.1349548.


The Journal Club: Highlights on Recent Papers-13.

Shiu P, DiStefano J, Alahari S, Enguita F, Feinberg M, Sideris N Noncoding RNA. 2023; 9(6).

PMID: 38133210 PMC: 10745700. DOI: 10.3390/ncrna9060076.


References
1.
Ayoubi S, Sheikh S, Eskildsen T . Human induced pluripotent stem cell-derived vascular smooth muscle cells: differentiation and therapeutic potential. Cardiovasc Res. 2017; 113(11):1282-1293. DOI: 10.1093/cvr/cvx125. View

2.
Cheung C, Bernardo A, Trotter M, Pedersen R, Sinha S . Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol. 2012; 30(2):165-73. PMC: 3272383. DOI: 10.1038/nbt.2107. View

3.
McPherson R . Chromosome 9p21.3 locus for coronary artery disease: how little we know. J Am Coll Cardiol. 2013; 62(15):1382-3. DOI: 10.1016/j.jacc.2013.07.032. View

4.
Roberts R, Stewart A . 9p21 and the genetic revolution for coronary artery disease. Clin Chem. 2011; 58(1):104-12. DOI: 10.1373/clinchem.2011.172759. View

5.
Cho H, Li Y, Archacki S, Wang F, Yu G, Chakrabarti S . Splice variants of lncRNA RNA ANRIL exert opposing effects on endothelial cell activities associated with coronary artery disease. RNA Biol. 2020; 17(10):1391-1401. PMC: 7549722. DOI: 10.1080/15476286.2020.1771519. View